These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 2503275)

  • 1. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
    Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
    Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG subclass responses to a transmembrane protein (gp41) peptide in HIV infection.
    Chiodi F; Mathiesen T; Albert J; Parks E; Norrby E; Wahren B
    J Immunol; 1989 Jun; 142(11):3809-14. PubMed ID: 2497181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
    Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
    AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides.
    Mathiesen T; Broliden PA; Rosen J; Wahren B
    Immunology; 1989 Aug; 67(4):453-9. PubMed ID: 2475432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.
    Lange JM; de Wolf F; Krone WJ; Danner SA; Coutinho RA; Goudsmit J
    AIDS; 1987 Sep; 1(3):155-9. PubMed ID: 3126756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages.
    Ljunggren K; Broliden PA; Morfeldt-Månson L; Jondal M; Wahren B
    Clin Exp Immunol; 1988 Sep; 73(3):343-7. PubMed ID: 3208446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of the antibody response and p24 antigenemia in HIV-1 infected individuals in Czechoslovakia].
    Kopecká D; Brůcková M; Stanková M; Syrůcek L; Vojtĕchovský K; Petkov V
    Cesk Epidemiol Mikrobiol Imunol; 1990 Mar; 39(2):65-73. PubMed ID: 2142624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1.
    Filice G; Cereda PM; Orsolini P; Soldini L; Romero E; Rondanelli EG
    Microbiologica; 1990 Jul; 13(3):215-24. PubMed ID: 2125683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
    O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.
    Ravanshad M; Sabahi F; Mahboudi F; Kazemnejad A
    Saudi Med J; 2006 Jan; 27(1):31-6. PubMed ID: 16432590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and characterization of HIV-1 Gag p17-p24 protein].
    Li TY; Jin NY; Wang HW; Guo ZR; Fang HH; An RG; Yin Z
    Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):65-8. PubMed ID: 10883279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal analysis of the antibody response to HIV envelope protein in HIV-infected laboratory workers.
    Pincus SH; Messer KG; Nara PL; Blattner WA; Colclough G; Reitz M
    J Clin Invest; 1994 Jun; 93(6):2505-13. PubMed ID: 7515393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
    Zwart G; van der Hoek L; Valk M; Cornelissen MT; Baan E; Dekker J; Koot M; Kuiken CL; Goudsmit J
    Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the presence of anti-protein gag antibodies as an evolution marker of HIV infection.
    Neguţ EA; Usein CR; Sfartz S; Zugun-Eloae F
    Roum Arch Microbiol Immunol; 1999; 58(2):131-46. PubMed ID: 11845452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
    Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
    Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and persistence of antibody titers to recombinant HIV-1 core and matrix proteins in HIV-1 infection.
    Janvier B; Mallet F; Cheynet V; Dalbon P; Vernet G; Besnier JM; Choutet P; Goudeau A; Mandrand B; Barin F
    J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):898-903. PubMed ID: 8315575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.
    Thomas HI; Wilson S; O'Toole CM; Lister CM; Saeed AM; Watkins RP; Morgan-Capner P
    Clin Exp Immunol; 1996 Feb; 103(2):185-91. PubMed ID: 8565298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.